Hildegard Buning

Hildegard Buning

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications

Novel VSV-G Variants with Enhanced Blinding for Targeted Delivery of Lentiviral Vectors.

Novel VSV-G Variants with Enhanced Blinding for Targeted Delivery of Lentiviral Vectors.

Journal: Human gene therapy
Published: August 03, 2026

Dichotomies in Ex Vivo and In Vivo Performance of Receptor-Binding Mutants of Adeno-Associated Virus Vectors.

Dichotomies in Ex Vivo and In Vivo Performance of Receptor-Binding Mutants of Adeno-Associated Virus Vectors.

Journal: Human gene therapy
Published: July 16, 2026

289th ENMC international workshop: assessing and managing emerging AAV related toxicities after gene therapy for neuromuscular disorders, 26 - 28 September 2025, Hoofddorp, The Netherlands.

289th ENMC international workshop: assessing and managing emerging AAV related toxicities after gene therapy for neuromuscular disorders, 26 - 28 September 2025, Hoofddorp, The Netherlands.

Journal: Neuromuscular disorders : NMD
Published: July 10, 2026

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Journal: Human gene therapy
Published: July 07, 2026

In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.

In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.

Journal: Human gene therapy
Published: June 18, 2026

In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.

In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.

Journal: Human gene therapy
Published: March 28, 2026

Therapeutic antibody delivery: vector tools to boost efficacy and affordability.

Therapeutic antibody delivery: vector tools to boost efficacy and affordability.

Journal: Frontiers in immunology
Published: September 27, 2025

Robust Functionality and Regulation of Selectively Expressed RNA as AAV Vectors and In Vitro Transcribed Molecules.

Robust Functionality and Regulation of Selectively Expressed RNA as AAV Vectors and In Vitro Transcribed Molecules.

Journal: Pharmaceutics
Published: September 19, 2025

Capsid-engineered AAV vector overcomes a key intracellular barrier and efficiently transduces spiral ganglion neurons in adult mice.

Capsid-engineered AAV vector overcomes a key intracellular barrier and efficiently transduces spiral ganglion neurons in adult mice.

Journal: Molecular therapy. Advances
Published: March 14, 2025

Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence.

Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence.

Journal: Biomedicines
Published: January 31, 2025

Pilocytic astrocytoma in a child with spinal muscular atrophy treated with onasemnogene abeparvovec.

Pilocytic astrocytoma in a child with spinal muscular atrophy treated with onasemnogene abeparvovec.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 06, 2024

Adeno-Associated Virus Vectors-a Target of Cellular and Humoral Immunity-are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies.

Adeno-Associated Virus Vectors-a Target of Cellular and Humoral Immunity-are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies.

Journal: Human gene therapy
Published: August 28, 2024
Showing 1-12 of 107

Last Updated: 09/26/2026